证书编号:(皖)-非经营性-2020-0054

Announcement of the State Food and Drug Administration on the upgrading and transformation of drug registration related systems (No.72 in 2020)

Column:INDUSTRY NEWS Time:2020-06-22 Browsing volume: 985
In order to ensure the smooth implementation of the newly revised "measures for the administration of drug registration", the State Drug Administration is speeding up the upgrading and transformation of the drug registration related systems.

In order to ensure the smooth implementation of the newly revised "measures for the administration of drug registration", the State Drug Administration is speeding up the upgrading and transformation of the drug registration related systems. The relevant matters are hereby announced as follows:

1、 On June 24, 2020, the new version of drug registration and application software for applicants will be released on the website of the State Drug Administration.

2、 From June 28 to June 30, in order to carry out the switching between the new and old systems and the joint debugging and testing, the State Drug Administration and the drug administration of all provinces (districts and cities) will suspend the use of the existing drug registration related systems, and the corresponding drug registration acceptance and certificate preparation and delivery business will also be suspended. In case of emergency, please contact the relevant departments of SFDA.

3、 From July 1, 2020, the State Food and Drug Administration will launch the new version of drug registration related system. Drug registration applicants are requested to download the latest version of the application software and submit registration applications as required.

Contact information of relevant working departments of SFDA: Drug Evaluation Center (acceptance business): 010-85242306; administrative matters acceptance service and complaint reporting center (certificate preparation business): 010-88331775, 88331720; Information Center (system upgrading and transformation business): 010-88331945, 88331909.



It is hereby announced.

State Food and Drug Administration

June 17, 2020